Neural activities of IL‐6‐type cytokines often depend on soluble cytokine receptors
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Cytokines of the interleukin‐6 (IL‐6) family participate in regulatory and inflammatory processes within the nervous system. IL‐6, ciliary neurotrophic factor (CNTF) and IL‐11 act via specific membrane receptors which, together with their ligands, associate with signal‐transducing receptor subunits thereby initiating cytoplasmic signalling. Cells which only express signal‐transducing receptor subunits but no ligand binding subunits for IL‐6, CNTF and IL‐11 are refractory to these cytokines. An unusual feature of the IL‐6 cytokine family is that the soluble forms of the ligand binding receptor subunits generated by one cell type in complex with their ligands can directly stimulate the signal‐transducing receptor subunits on different cell types which lack ligand binding receptor subunits. This process has been named transsignalling. This article focuses on the importance of transsignalling events in neuronal differentiation and survival responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impaired immune and acute-phase responses in interleukin-6-deficient mice
Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., & Köhler, G. (1994) · Nature · doi:10.1038/368339a0 · Cited by 1,768 · cited 5×
“While IL-6±/±, IL-11R±/±, CNTF±/± and LIF±/± mice show no or a very mild phenotype when compared with control mice (Escary et al., 1993; Masu et al., 1993; Kopf et al., 1994; Nandurkar et al., 1997), animals lacking gp130 or LIF-R die perinatally and neuronal de®ciencies cannot be studied easily (Ware et al., 1995; Yo…”
BackgroundInfluentialInterleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T., & Kishimoto, T. (1989) · Cell · doi:10.1016/0092-8674(89)90438-8 · Cited by 1,396 · cited 1×
“Taga et al. were the ®rst to describe that sIL-6R can associate with gp130 in the presence of IL-6 and mediate its function (Taga et al., 1989).”
BackgroundMCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287 · cited 1×
“In recent years experimental data have accumulated indicating that a chronic in¯ammatory process is part of the pathology of Alzheimer's disease (AD) (McGeer & McGeer, 1995).”
BackgroundNeurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6.
Campbell, I. L., Abraham, C. R., Masliah, E., Kemper, P., Inglis, J. D., Oldstone, M. B., & Mucke, L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10061 · Cited by 1,006
Blum-Degena, D., Müller, T., Kuhn, W., Gerlach, M., Przuntek, H., & Riederer, P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12192-7 · Cited by 801
Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease cortices
Bauer, J., Strauss, S., Schreiter-Gasser, U., Ganter, U., Schlegel, P., Witt, I., Yolk, B., & Berger, M. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80737-n · Cited by 483
Wood, J. A., Wood, P. L., Ryan, R., Graff-Radford, N. R., Pilapil, C., Robitaille, Y., & Quirion, R. (1993) · Brain Research · doi:10.1016/0006-8993(93)91327-o · Cited by 244 · cited 1×
“…AD patients (HuÈll et al., 1995; HuÈll et al., 1996); (ii) IL-6-positive plaques show increased levels of acute-phase proteins (Bauer et al., 1991; Wood et al., 1993); (iii) IL6 and other cytokines such as IL-1b regulate amyloid precursor protein expression in neurons and astrocytes (Brugg et…”
BackgroundHuell, M., Strauss, S., Volk, B., Berger, M., & Bauer, J. (1995) · Acta Neuropathologica · doi:10.1007/bf00571510 · Cited by 214
Wu, Y. Y., & Bradshaw, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.13023 · Cited by 100
Cited by
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Scheller, J., Chalaris, A., Schmidt-Arras, D., & Rose-John, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.034 · Cited by 3,212
Self-citationKawasaki, Y., Zhang, L., Cheng, J.-K., & Ji, R.-R. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3338-07.2008 · Cited by 1,162
“Effects of soluble IL-6 receptor on synaptic transmission, CREB phosphorylation, and pain behavior Unlike IL-1 and TNF , sIL-6R is required for IL-6 effects in neurons because membrane-bound IL-6 receptor may express at very low levels in neurons (März et al., 1999; Opree and Kress, 2000).”
BackgroundInterleukin-6, a Major Cytokine in the Central Nervous System
Erta, M., Quintana, A., & Hidalgo, J. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4679 · Cited by 1,087
Rose-John, S., Scheller, J., Elson, G., & Jones, S. A. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1105674 · Cited by 647
Self-citationSoluble gp130 is the natural inhibitor of soluble interleukin‐6 receptor transsignaling responses
Jostock, T., Müllberg, J., Özbek, S., Atreya, R., Blinn, G., Voltz, N., Fischer, M., Neurath, M. F., & Rose‐John, S. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01867.x · Cited by 641
Self-citation
Metadata
- Authors
- März, P., Otten, U., & Rose‐John, S.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 1999-09
- Volume
- 11
- Issue
- 9
- Pages
- 2995-3004
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2055016638
- Cited by
- 126
- References
- 9
- FWCI
- 3.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neural activities of IL‐6‐type cytokines often depend on soluble cytokine receptors. https://app.cochat.ai/papers/10.1046/j.1460-9568.1999.00755.x
- The paper
- März, P., Otten, U., & Rose‐John, S. (1999). Neural activities of IL‐6‐type cytokines often depend on soluble cytokine receptors. European Journal of Neuroscience. https://doi.org/10.1046/j.1460-9568.1999.00755.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.